Tg Therapeutics (TGTX) Asset Utilization Ratio: 2016-2025
Historic Asset Utilization Ratio for Tg Therapeutics (TGTX) over the last 9 years, with Sep 2025 value amounting to 0.62.
- Tg Therapeutics' Asset Utilization Ratio rose 14.79% to 0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year increase of 14.79%. This contributed to the annual value of 0.73 for FY2024, which is 18.81% down from last year.
- Latest data reveals that Tg Therapeutics reported Asset Utilization Ratio of 0.62 as of Q3 2025, which was down 7.83% from 0.67 recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Asset Utilization Ratio ranged from a high of 0.90 in Q2 2024 and a low of 0.00 during Q1 2021.
- In the last 3 years, Tg Therapeutics' Asset Utilization Ratio had a median value of 0.63 in 2025 and averaged 0.57.
- As far as peak fluctuations go, Tg Therapeutics' Asset Utilization Ratio skyrocketed by 5,127.30% in 2023, and later declined by 25.38% in 2025.
- Tg Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.02 in 2021, then declined by 20.16% to 0.01 in 2022, then spiked by 5,127.30% to 0.71 in 2023, then dropped by 20.06% to 0.57 in 2024, then increased by 14.79% to 0.62 in 2025.
- Its Asset Utilization Ratio was 0.62 in Q3 2025, compared to 0.67 in Q2 2025 and 0.63 in Q1 2025.